D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications
J Favresse, G Lippi, PM Roy, B Chatelain… - Critical reviews in …, 2018 - Taylor & Francis
D-dimer is a soluble fibrin degradation product deriving from the plasmin-mediated
degradation of cross-linked fibrin. D-dimer can hence be considered a biomarker of …
degradation of cross-linked fibrin. D-dimer can hence be considered a biomarker of …
[PDF][PDF] Guidelines on oral anticoagulation with warfarin
1.1 Žilní trombembolismus Cílová hodnota INR u první epizody žilního trombembolismu má
být 2, 5. V úvodu léčby se má současně s užíváním warfarinu zahájit také parenterální …
být 2, 5. V úvodu léčby se má současně s užíváním warfarinu zahájit také parenterální …
[图书][B] How to read a paper: the basics of evidence-based medicine and healthcare
T Greenhalgh - 2019 - books.google.com
Required reading in many medical and healthcare institutions, How to Read a Paper is a
clear and wide-ranging introduction to evidence-based medicine and healthcare, helping …
clear and wide-ranging introduction to evidence-based medicine and healthcare, helping …
[HTML][HTML] Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)
Background: In patients with unprovoked venous thromboembolism (VTE), the optimal
duration of anticoagulation is anchored on estimating the risk of disease recurrence …
duration of anticoagulation is anchored on estimating the risk of disease recurrence …
Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model
S Eichinger, G Heinze, LM Jandeck, PA Kyrle - Circulation, 2010 - Am Heart Assoc
Background—Predicting the risk of recurrent venous thromboembolism (VTE) in an
individual patient is often not feasible. We aimed to develop a simple risk assessment model …
individual patient is often not feasible. We aimed to develop a simple risk assessment model …
[PDF][PDF] Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study
Objective To prospectively validate the HERDOO2 rule (Hyperpigmentation, Edema, or
Redness in either leg; D-dimer level≥ 250 μg/L; Obesity with body mass index≥ 30; or …
Redness in either leg; D-dimer level≥ 250 μg/L; Obesity with body mass index≥ 30; or …
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of …
F Boutitie, L Pinede, S Schulman, G Agnelli, G Raskob… - Bmj, 2011 - bmj.com
Objective To determine how length of anticoagulation and clinical presentation of venous
thromboembolism influence the risk of recurrence after anticoagulant treatment is stopped …
thromboembolism influence the risk of recurrence after anticoagulant treatment is stopped …
Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism
It takes about 3 months to complete “active treatment” of venous thromboembolism (VTE),
with further treatment serving to prevent new episodes of thrombosis (“pure secondary …
with further treatment serving to prevent new episodes of thrombosis (“pure secondary …
Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review
Background We aimed to determine the risk of recurrence for symptomatic venous
thromboembolism (VTE) provoked by different transient risk factors. Data Sources MEDLINE …
thromboembolism (VTE) provoked by different transient risk factors. Data Sources MEDLINE …
Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism
Background: Case-fatality rates are important for assessing the risks and benefits of
anticoagulation in patients with venous thromboembolism (VTE). Purpose: To summarize …
anticoagulation in patients with venous thromboembolism (VTE). Purpose: To summarize …